Table 1 Patient characteristics
All patients (n = 87) (%) | |
|---|---|
Sex | |
Male | 34 (39.1) |
Female | 53 (60.9) |
Age, y (range) | 92 (90–98) |
Body mass index, kg/m2 (range) | 19.9 (12.9–30.0) |
ASA performance status | |
1 | 9 (10.3) |
2 | 50 (57.5) |
3 | 27 (31.0) |
4 | 1 (1.1) |
Comorbidities, present | 78 (89.7) |
Hypertension | 44 (50.5) |
Diabetes mellitus | 14 (16.1) |
Heart failure | 13 (14.9) |
Dementia | 9 (10.3) |
Angina pectoris / myocardial infarction | 7 (8.0) |
Valvular disease | 7 (8.0) |
Other cancer | 6 (6.9) |
Renal failure | 6 (6.9) |
Arrhythmia | 6 (6.9) |
Chronic obstructive pulmonary disease | 4 (4.6) |
Collagen disease | 1 (1.1) |
Tumor location | |
Cecum | 12 (13.8) |
Ascending colon | 21 (24.1) |
Transverse colon | 15 (17.2) |
Descending colon | 5 (5.7) |
Sigmoid colon | 13 (14.9) |
Rectum | 21 (24.1) |
Operative procedure | |
Ileocecal resection | 20 (23.0) |
Hemicolectomy | 21 (24.1) |
Partial resection | 9 (10.3) |
Sigmoidectomy | 9 (10.3) |
Anterior resection | 9 (10.3) |
Hartmann | 10 (11.5) |
Abdominoperineal resection | 9 (10.3) |
Clinical T factor | |
1 | 7 (8.0) |
2 | 12 (13.8) |
3 | 45 (51.7) |
4 | 23 (26.4) |
Clinical N factor | |
0 | 47 (54.0) |
1 | 27 (31.0) |
2 | 12 (13.8) |
Distant metastasis, present | 7 (8.0) |
Operation time, min (range) | 187 (60–560) |
Blood loss, mL (range) | 35 (0–843) |
Blood transfusion, yes | 22 (25.3) |
Open conversion | 1 (1.1) |
Postoperative complications, CD ≥ 2 | 35 (40.2) |
Duration of urethral catheter removal, days (range) | 3 (2–7) |
Hospital stay, days (range) | 19 (7–140) |
Re-admission within 30 days, yes | 4 (4.6) |